Five Filters. One Signal.
Our disciplined approach focuses on companies with demonstrated product readiness, strong technical leadership, and scalable solutions in healthcare innovation.
Our Core Filters
- Geography: Global mandate with sharp focus on companies based in India or led by founders of Indian origin. Expanding into Africa via our upcoming SPAC.
- Time: We invest post-product readiness and initial market validation — typically Series A and beyond.
- People: Exceptional founders with conviction, depth, and at least one technical co-founder.
- Cheque Size: Minimum US$ 10 Million — providing meaningful capital to accelerate growth.
- Industry Focus: Healthcare, HealthTech, Drug Discovery, Pharma Manufacturing, MedTech, Device Technology, and AI for Computer-Aided Drug Discovery (CADD).
Portfolio Construction
Launching Soon
Fund IV: Next-generation global healthcare innovation vehicle.
Africa-Focused SPAC: Targeting high-potential healthcare and biotech opportunities across the African continent, leveraging our emerging markets expertise.
Fund II – Launched June 2024 – $350 Million Scaled deployment with larger cheques and deeper value-add support.
Fund III – Launched December 2025 – $450 Million India-focused vehicle targeting Series A & B opportunities in drug discovery, healthcare, and MedTech.